Suppr超能文献

在低心输出量情况下血管活性和正性肌力药物对胃肠道影响的随机猪研究。

A Randomized Porcine Study in Low Cardiac Output of Vasoactive and Inotropic Drug Effects on the Gastrointestinal Tract.

机构信息

Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Department of Anaesthesiology and Intensive Care, Skaraborg Hospital, Skövde, Sweden.

出版信息

Shock. 2021 Aug 1;56(2):308-317. doi: 10.1097/SHK.0000000000001726.

Abstract

BACKGROUND

Splanchnic vasodilation by inodilators is an argument for their use in critical cardiac dysfunction. To isolate peripheral vasoactivity from inotropy, such drugs were investigated, and contrasted to vasopressors, in a fixed low cardiac output (CO) model resembling acute cardiac dysfunction effects on the gastrointestinal tract. We hypothesized that inodilators would vasodilate and preserve the aerobic metabolism in the splanchnic circulation in low CO.

METHODS

In anesthetized pigs, CO was lowered to 60% of baseline by partial inferior caval vein balloon inflation. The animals were randomized to placebo (n = 8), levosimendan (24 μg kg-1 bolus, 0.2 μg kg-1 min-1, n = 7), milrinone (50 μg kg-1 bolus, 0.5 μg kg-1 min-1, n = 7), vasopressin (0.001, 0.002 and 0.006 U kg-1 min-1, 1 h each, n = 7) or norepinephrine (0.04, 0.12, and 0.36 μg kg-1 min-1, 1 h each, n = 7). Hemodynamic variables including mesenteric blood flow were collected. Systemic, mixed-venous, mesenteric-venous, and intraperitoneal metabolites were analyzed.

RESULTS

Cardiac output was stable at 60% in all groups, which resulted in systemic hypotension, low superior mesenteric artery blood flow, lactic acidosis, and increased intraperitoneal concentrations of lactate. Levosimendan and milrinone did not change any circulatory variables, but levosimendan increased blood lactate concentrations. Vasopressin and norepinephrine increased systemic and mesenteric vascular resistances at the highest dose. Vasopressin increased mesenteric resistance more than systemic, and the intraperitoneal lactate concentration and lactate/pyruvate ratio.

CONCLUSION

Splanchnic vasodilation by levosimendan and milrinone may be negligible in low CO, thus rejecting the hypothesis. High-dose vasopressors may have side effects in the splanchnic circulation.

摘要

背景

通过舒张内脏血管的药物(即所谓的“正性肌力血管扩张剂”)治疗心脏功能不全的理论依据之一是其舒张内脏血管的作用。为了将药物的外周血管扩张作用与正性肌力作用分离开来,人们设计了这类药物,并将其与血管加压素类药物进行对比,在一个固定的低心输出量(CO)模型中模拟急性心功能不全对胃肠道的影响。我们假设正性肌力血管扩张剂在低 CO 时能舒张内脏血管并维持内脏循环的有氧代谢。

方法

在麻醉猪模型中,通过部分下腔静脉球囊充气将 CO 降低至基础值的 60%。动物被随机分为安慰剂组(n=8)、左西孟旦组(24μg/kg 负荷剂量,0.2μg/kg/min 维持剂量,n=7)、米力农组(50μg/kg 负荷剂量,0.5μg/kg/min 维持剂量,n=7)、血管加压素组(0.001、0.002 和 0.006 U/kg/min,持续 1 小时,n=7)或去甲肾上腺素组(0.04、0.12 和 0.36μg/kg/min,持续 1 小时,n=7)。收集血流动力学变量,包括肠系膜血流。分析系统、混合静脉、肠系膜静脉和腹腔内代谢物。

结果

所有组的 CO 均稳定在 60%,导致全身低血压、肠系膜上动脉血流减少、乳酸酸中毒和腹腔内乳酸浓度增加。左西孟旦和米力农均未改变任何循环变量,但左西孟旦增加了血乳酸浓度。血管加压素和去甲肾上腺素在最高剂量时增加了全身和肠系膜血管阻力。血管加压素增加肠系膜阻力的程度大于全身,且增加了腹腔内乳酸浓度和乳酸/丙酮酸比值。

结论

在低 CO 时,左西孟旦和米力农引起的内脏血管舒张作用可能微不足道,从而否定了该假说。高剂量的血管加压素类药物可能会对内脏循环产生副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e39d/8529897/77c40112f959/shk-56-308-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验